Physician profile
Steven Hollenberg
NPI 1811079130
$1,664.43
in general payments reported to CMS, 2019-2025
14 companies · $335 in 2025
The $335 reported for 2025 was less than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $192 · 2020: $18.81 · 2021: $467 · 2022: $125 · 2023: $390 · 2024: $137 · 2025: $335.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $862.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $861.96 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Getinge USA Sales, LLC | $207.79 | 2023-2024 | Cardiohelp, Base Unit Servo-U |
| Impulse Dynamics (USA) INC. | $168.56 | 2025 | Optimizer |
| Ancora Heart, INC. | $164.00 | 2019 | |
| Edwards Lifesciences Corporation | $162.22 | 2021 | |
| Abiomed | $149.28 | 2021 | |
| Btg International INC. | $149.14 | 2025 | |
| Teleflex LLC | $144.08 | 2023 | Arrow |
| Astrazeneca Pharmaceuticals LP | $134.00 | 2023 | Andexxa |
| Penumbra, INC. | $124.86 | 2022 | |
| Alexion Pharmaceuticals, INC. | $97.60 | 2021 | |
| Angiodynamics, INC. | $58.39 | 2024-2025 | Alphavac |
| Fisher Scientific Company L.L.C. | $57.61 | 2021 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $35.15 | 2019-2020 | |
| Pfizer INC. | $11.75 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Steven Hollenberg listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.